AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2021 Issue 4; Section X-New Technology
Transfusion of Hyperimmune Globulin and High-Dose Immune Globulin
In code Table XW1, Anatomical Regions, Transfusion, new Substance values D High-Dose Intravenous Immune Globulin and E Hyperimmune Globulin, were created. The change allows the identification of the intravenous administration of these substances to enable efficient tracking when used for the treatment of COVID-19. Body Part Approach Device/ Substance/ Technology Qualifier 3 Peripheral Vein 4 Central Vein 3 Percutaneous D High-Dose Intravenous Immune Globulin E Hyperimmune Globulin 7 New Technology Group 7 ...
Subscribe or sign in to view the full article.
Article Overview
This article covers a coding change in ICD-10-PCS related to transfusion procedures and the addition of new substance values for immune globulin-related intravenous administration. It is relevant to coding professionals, clinical documentation staff, and healthcare organizations that track procedure reporting changes, especially in the context of COVID-19-era treatment tracking. The article provides a brief overview of the affected table structure and the new values added.
Why This Topic Matters
It matters because procedure coding updates can affect how transfusion-related services are captured and reported in health records and data systems.
What You Will Learn
- What coding area was updated
- What type of procedure table was affected
- How the update supports procedure tracking
- The general context for the change
Who Should Read This
- Medical coders
- Coding auditors
- Clinical documentation specialists
- Health information management professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com